Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Newling

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Progress in Clinical and Biological Research|January 1, 1988
The assessment of patients with invasive bladder cancer prior to definitive treatment to enable individual planning of the most appropriate therapyD W Newling
Urology|August 15, 2001
Early versus late androgen deprivation therapy in metastatic diseaseD W Newling
Progress in Clinical and Biological Research|January 1, 1990
The evolution of active chemotherapy in metastatic and locally advanced bladder cancerD W Newling
British Journal of Urology|June 1, 1996
Anti-androgens in the treatment of prostate cancerD W Newling
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1995
Update on urology--prostate cancer. 1--The molecular basis for prostatic cancer: how it may influence treatment choiceD W Newling
Progress in Clinical and Biological Research|January 1, 1991
Organ conservation in bladder cancerD W Newling
Der Urologe. Ausg. A|September 1, 1995
[Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations]D W Newling
European Urology|January 1, 1990
The response of advanced prostatic cancer to a new non-steroidal antiandrogen: results of a multicenter open phase II study of Casodex. European/Australian Co-operative GroupD W Newling
European Urology|January 1, 1997
Clinical assessment and management of stage T3 prostate cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1989
The use of flutamide as monotherapy in the treatment of advanced prostate cancerD W Newling
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Progress in Clinical and Biological Research|January 1, 1988
The assessment of patients with invasive bladder cancer prior to definitive treatment to enable individual planning of the most appropriate therapyD W Newling
Urology|August 15, 2001
Early versus late androgen deprivation therapy in metastatic diseaseD W Newling
Progress in Clinical and Biological Research|January 1, 1990
The evolution of active chemotherapy in metastatic and locally advanced bladder cancerD W Newling
British Journal of Urology|June 1, 1996
Anti-androgens in the treatment of prostate cancerD W Newling
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1995
Update on urology--prostate cancer. 1--The molecular basis for prostatic cancer: how it may influence treatment choiceD W Newling
Progress in Clinical and Biological Research|January 1, 1991
Organ conservation in bladder cancerD W Newling
Der Urologe. Ausg. A|September 1, 1995
[Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations]D W Newling
European Urology|January 1, 1990
The response of advanced prostatic cancer to a new non-steroidal antiandrogen: results of a multicenter open phase II study of Casodex. European/Australian Co-operative GroupD W Newling
European Urology|January 1, 1997
Clinical assessment and management of stage T3 prostate cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1989
The use of flutamide as monotherapy in the treatment of advanced prostate cancerD W Newling
Pageof 11